Connect your AI

Haemonetics HAE Total Current Assets

Total Current Assets at other companies

AbbottABT

$25.51B+10.2%

TFX

TeleflexTFX

$1.86B+20.8%

Boston ScientificBSX

$8.68B+18.4%

MedtronicMDT

$24.79B+4.1%

LivaNovaLIVN

$1.01B-13.4%

ICU MedicalICUI

$1.21B-14.8%

Other financials

Income statement

Revenue$346.4M+4.8%

Gross profit$198.2M+2.7%

Operating income$67.4M+14.2%

Net income$44.7M+19.3%

EPS (diluted)$0.95+28.4%

Balance sheet

Cash & equivalents$245.4M-20.0%

Total debt$1.3B-0.7%

Total equity$796.3M-3.0%

Total assets$2.4B-2.2%

Cash flow

Operating cash flow$70.9M-39.1%

CapEx$17.7M+12.9%

Free cash flow$53.3M-47.2%

Valuation

Market cap$3.37B-18.0%

Enterprise value$4.4B-12.5%

P/S2.5×-0.5×

Profitability

Gross margin59%+4.0pp

Operating margin19%+5.9pp

Net margin13.3%+3.8pp

FCF margin19.5%+9.1pp

Returns & leverage

Return on equity19.3%+5.2pp

Debt / equity1.6×0.0×

Current ratio3×+1.3×

Where this comes from

Reported directly by Haemonetics in its filing.

Tagged under the XBRL concept us-gaap:AssetsCurrent.

The official record: Haemonetics’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →

Ask your AI about Haemonetics's total current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Haemonetics's total current assets?: Haemonetics (HAE) reported total current assets of $834.88M in Q1 2026.
How has Haemonetics's total current assets changed year-over-year?: Haemonetics's total current assets decreased by 10.7% year-over-year, from $934.98M to $834.88M.
What is the long-term trend for Haemonetics's total current assets?: Over 5 years (2021 to 2026), Haemonetics's total current assets has grown at a 3.8% compound annual growth rate (CAGR), from $693.55M to $834.88M.
What does total current assets mean?: The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.